Accelerating drug discovery, dietary supplements, and botanical cosmetics from early-stage screening to regulatory clinical trials.
In response to supply-chain re-shoring, stringent pharmacopeial harmonizations, and increasing demand for reproducible natural APIs, international bio-pharma enterprises require technically robust manufacturing alliances.
Global procurement teams face increasing volatility in raw botanical pricing and geo-climatic quality shifts. China's contract manufacturing ecosystem provides unparalleled access to GAP-certified cultivation bases and raw-material traceability.
Translating traditional empirical remedies into acceptable dossiers for Western health authorities requires strict compliance with US FDA 21 CFR Part 111/211 and European Pharmacopoeia (Ph. Eur.) guidelines.
Mitigate the classical "valley of death" between benchtop academic isolation and cubic-meter commercial production with fully integrated pilot extraction infrastructure.
Over a decade and a half of verified scientific execution across pharmaceutical manufacturing groups, clinical academies, and TCM hospital registrations.
Our strategic engineering blueprint addresses next-generation bioavailability enhancement, enzymatic biotransformation, and green solvent extraction.
Eliminating halogenated hydrocarbon residues through super-critical CO2 with organic co-solvents, preserving sensitive polyphenols and non-polar terpene profiles.
Overcoming low oral bioavailability in difficult herbal actives (e.g., Curcuminoids, Berberine, Resveratrol) through phospholipid complexes and nano-emulsion pre-concentrates.
Harnessing specific microbial glycosidases to biotransform standard ginsenosides and saponins into high-potency rare metabolites (e.g., Ginsenoside Rh2, Compound K).
Utilizing high-throughput molecular docking and network biology models to establish target affinity vectors prior to running benchtop cell-line validations.
Implementing near-infrared spectroscopy across industrial extraction and distillation vessels for dynamic process trajectory control and zero-defect consistency.
Streamlined technical files adhering simultaneously to USP Botanical Dietary Supplement Monographs, British Herbal Pharmacopoeia, and China Pharmacopoeia (ChP).
We solve the critical governance concerns of North American, European, and Asia-Pacific procurement directors through ironclad IP safeguards and rigorous Quality Management Systems.
All tech transfers, process parameters, chromatograms, and formula designs are legally shielded under enforceable bilateral contracts. Production line runs are compartmentalized with segmented data silos.
Auditable batch production records (BPR), computerized audit trails compliant with FDA 21 CFR Part 11, and certified analytical results (CoA) provided for every individual active raw or packaged SKU lot.
Our dedicated regulatory and logistics personnel ensure smooth passage through international inspection barriers via complete CITES clearance, botanical species authentication, and non-GMO/irradiation statements.
Demonstrated delivery history across 33 prominent state organizations, listed biopharma entities, and academic clinical hospitals.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtzi River Pharma
Beihai Gofar
Humanwell Health
SCIMYTH Pharma
Hanfang Pharma
Luoxin Pharma
Zhongsheng Pharma
Brilliance Herbal
Apeloa Pharma
Heng Chang Pharma
Baotou TCM
Kamp Medicine
Santo Pharma
Kangshou Pharma
Juwang Pharma
Tcmages Pharma
Ruihe Pharma
CR Jinchan
Kangmei Pharma
Tianjicaotang
Kingstone Unite
Shuguang Hospital
Hunan TCM Hospital
First Hosp. Hunan TCM
2nd Xiangya Hospital
2nd Hosp. Hunan TCM
Zhuzhou Orthopedics TCMDirect responses to technical, operational, and regulatory inquiries commonly raised by biopharmaceutical procurement auditors.
Access our validated scientific platforms and turnkey OEM/CDMO manufacturing lines.
